Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“One of these other contenders for “first novel psychedelic” is, of course, psilocybin.”
· Yet More Data on Psychedelics in Veterans with Depression · substack post

The author frames psilocybin, specifically COMPASS Pathways' COMP360 (which he called 'a Christmas miracle' the prior year), as a contender to be the first novel psychedelic to reach approval after the MDMA-AT setback.

Descriptive, retrospective, or a statement of preference; no future state asserted.